1
|
Tan S, Yang W, Ren Z, Peng Q, Xu X, Jiang X, Wu Z, Oyang L, Luo X, Lin J, Xia L, Peng M, Wu N, Tang Y, Han Y, Liao Q, Zhou Y. Noncoding RNA-encoded peptides in cancer: biological functions, posttranslational modifications and therapeutic potential. J Hematol Oncol 2025; 18:20. [PMID: 39972384 PMCID: PMC11841355 DOI: 10.1186/s13045-025-01671-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2024] [Accepted: 02/07/2025] [Indexed: 02/21/2025] Open
Abstract
In the present era, noncoding RNAs (ncRNAs) have become a subject of considerable scientific interest, with peptides encoded by ncRNAs representing a particularly promising avenue of investigation. The identification of ncRNA-encoded peptides in human cancers is increasing. These peptides regulate cancer progression through multiple molecular mechanisms. Here, we delineate the patterns of diverse ncRNA-encoded peptides and provide a synopsis of the methodologies employed for the identification of ncRNAs that possess the capacity to encode these peptides. Furthermore, we discuss the impacts of ncRNA-encoded peptides on the biological behavior of cancer cells and the underlying molecular mechanisms. In conclusion, we describe the prospects of ncRNA-encoded peptides in cancer and the challenges that need to be overcome.
Collapse
Affiliation(s)
- Shiming Tan
- The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Hunan Key Laboratory of Cancer Metabolism, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China
| | - Wenjuan Yang
- The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Hunan Key Laboratory of Cancer Metabolism, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China
| | - Zongyao Ren
- The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Hunan Key Laboratory of Cancer Metabolism, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China
- Hunan Engineering Research Center of Tumor Organoid Technology and Applications, Public Service Platform of Tumor Organoid Technology, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China
| | - Qiu Peng
- The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Hunan Key Laboratory of Cancer Metabolism, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China
- Hunan Engineering Research Center of Tumor Organoid Technology and Applications, Public Service Platform of Tumor Organoid Technology, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China
| | - Xuemeng Xu
- The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Hunan Key Laboratory of Cancer Metabolism, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China
- Hunan Engineering Research Center of Tumor Organoid Technology and Applications, Public Service Platform of Tumor Organoid Technology, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China
| | - Xianjie Jiang
- The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Hunan Key Laboratory of Cancer Metabolism, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China
- Hunan Engineering Research Center of Tumor Organoid Technology and Applications, Public Service Platform of Tumor Organoid Technology, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China
| | - Zhu Wu
- The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Hunan Key Laboratory of Cancer Metabolism, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China
- Hunan Engineering Research Center of Tumor Organoid Technology and Applications, Public Service Platform of Tumor Organoid Technology, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China
| | - Linda Oyang
- The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Hunan Key Laboratory of Cancer Metabolism, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China
- Hunan Engineering Research Center of Tumor Organoid Technology and Applications, Public Service Platform of Tumor Organoid Technology, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China
| | - Xia Luo
- The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Hunan Key Laboratory of Cancer Metabolism, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China
- Hunan Engineering Research Center of Tumor Organoid Technology and Applications, Public Service Platform of Tumor Organoid Technology, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China
| | - Jinguan Lin
- The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Hunan Key Laboratory of Cancer Metabolism, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China
- Hunan Engineering Research Center of Tumor Organoid Technology and Applications, Public Service Platform of Tumor Organoid Technology, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China
| | - Longzheng Xia
- The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Hunan Key Laboratory of Cancer Metabolism, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China
- Hunan Engineering Research Center of Tumor Organoid Technology and Applications, Public Service Platform of Tumor Organoid Technology, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China
| | - Mingjing Peng
- The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Hunan Key Laboratory of Cancer Metabolism, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China
- Hunan Engineering Research Center of Tumor Organoid Technology and Applications, Public Service Platform of Tumor Organoid Technology, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China
| | - Nayiyuan Wu
- The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Hunan Key Laboratory of Cancer Metabolism, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China
- Hunan Engineering Research Center of Tumor Organoid Technology and Applications, Public Service Platform of Tumor Organoid Technology, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China
| | - Yanyan Tang
- The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Hunan Key Laboratory of Cancer Metabolism, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China
- Hunan Engineering Research Center of Tumor Organoid Technology and Applications, Public Service Platform of Tumor Organoid Technology, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China
| | - Yaqian Han
- The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Hunan Key Laboratory of Cancer Metabolism, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China.
- Hunan Engineering Research Center of Tumor Organoid Technology and Applications, Public Service Platform of Tumor Organoid Technology, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China.
| | - Qianjin Liao
- Department of Oncology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 410005, Hunan, People's Republic of China.
| | - Yujuan Zhou
- The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Hunan Key Laboratory of Cancer Metabolism, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China.
- Hunan Engineering Research Center of Tumor Organoid Technology and Applications, Public Service Platform of Tumor Organoid Technology, 283 Tongzipo Road, Changsha, 410013, Hunan, People's Republic of China.
| |
Collapse
|
3
|
Platero AI, Pueyo JI, Bishop SA, Magny EG, Couso JP. Pervasiveness of Microprotein Function Amongst Drosophila Small Open Reading Frames (SMORFS). Cells 2024; 13:2090. [PMID: 39768181 PMCID: PMC11674832 DOI: 10.3390/cells13242090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2024] [Revised: 11/29/2024] [Accepted: 12/09/2024] [Indexed: 01/11/2025] Open
Abstract
Small Open Reading Frames (smORFs) of less than 100 codons remain mostly uncharacterised. About a thousand smORFs per genome encode peptides and microproteins about 70-80 aa long, often containing recognisable protein structures and markers of translation, and these are referred to as short Coding Sequences (sCDSs). The characterisation of individual sCDSs has provided examples of smORFs' function and conservation, but we cannot infer the functionality of all other metazoan smORFs from these. sCDS function has been characterised at a genome-wide scale in yeast and bacteria, showing that hundreds can produce a phenotype, but attempts in metazoans have been less successful. Either most sCDSs are not functional, or classic experimental techniques do not work with smORFs due to their shortness. Here, we combine extensive proteomics with bioinformatics and genetics in order to detect and corroborate sCDS function in Drosophila. Our studies nearly double the number of sCDSs with detected peptides and microproteins and an experimentally corroborated function. Finally, we observe a correlation between proven sCDS protein function and bioinformatic markers such as conservation and GC content. Our results support that sCDSs peptides and microproteins act as membrane-related regulators of canonical proteins, regulators whose functions are best understood at the cellular level, and whose mutants produce little, if any, overt morphological phenotypes.
Collapse
Affiliation(s)
- Ana Isabel Platero
- Centro Andaluz de Biologia del Desarrollo, Universidad Pablo de Olavide, CSIC, 41013 Sevilla, Spain; (A.I.P.); (S.A.B.)
| | - Jose Ignacio Pueyo
- Brighton and Sussex Medical School, University of Sussex, Falmer, Brighton BN1 9PS, UK;
| | - Sarah Anne Bishop
- Centro Andaluz de Biologia del Desarrollo, Universidad Pablo de Olavide, CSIC, 41013 Sevilla, Spain; (A.I.P.); (S.A.B.)
- Brighton and Sussex Medical School, University of Sussex, Falmer, Brighton BN1 9PS, UK;
| | - Emile Gerard Magny
- Centro Andaluz de Biologia del Desarrollo, Universidad Pablo de Olavide, CSIC, 41013 Sevilla, Spain; (A.I.P.); (S.A.B.)
- Department of Molecular & Cellular Physiology and Institute of Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94035, USA
| | - Juan Pablo Couso
- Centro Andaluz de Biologia del Desarrollo, Universidad Pablo de Olavide, CSIC, 41013 Sevilla, Spain; (A.I.P.); (S.A.B.)
| |
Collapse
|
4
|
Hara T, Meng S, Tsuji Y, Arao Y, Saito Y, Sato H, Motooka D, Uchida S, Ishii H. RN7SL1 may be translated under oncogenic conditions. Proc Natl Acad Sci U S A 2024; 121:e2312322121. [PMID: 38478683 PMCID: PMC10962956 DOI: 10.1073/pnas.2312322121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2023] [Accepted: 01/29/2024] [Indexed: 03/27/2024] Open
Abstract
RN7SL1 (RNA component of signal recognition particle 7SL1), a component of the signal recognition particle, is a non-coding RNA possessing a small ORF (smORF). However, whether it is translated into peptides is unknown. Here, we generated the RN7SL1-Green Fluorescent Protein (GFP) gene, in which the smORF of RN7SL1 was replaced by GFP, introduced it into 293T cells, and observed cells emitting GFP fluorescence. Furthermore, RNA-seq of GFP-positive cells revealed that they were in an oncogenic state, suggesting that RN7SL1 smORF may be translated under special conditions.
Collapse
Affiliation(s)
- Tomoaki Hara
- Department of Medical Data Science, Center of Medical Innovation and Translational Research, Osaka University Graduate School of Medicine, Suita, Osaka565-0871, Japan
| | - Sikun Meng
- Department of Medical Data Science, Center of Medical Innovation and Translational Research, Osaka University Graduate School of Medicine, Suita, Osaka565-0871, Japan
| | - Yoshiko Tsuji
- Department of Medical Data Science, Center of Medical Innovation and Translational Research, Osaka University Graduate School of Medicine, Suita, Osaka565-0871, Japan
| | - Yasuko Arao
- Department of Medical Data Science, Center of Medical Innovation and Translational Research, Osaka University Graduate School of Medicine, Suita, Osaka565-0871, Japan
| | - Yoshiko Saito
- Department of Medical Data Science, Center of Medical Innovation and Translational Research, Osaka University Graduate School of Medicine, Suita, Osaka565-0871, Japan
| | - Hiromichi Sato
- Department of Medical Data Science, Center of Medical Innovation and Translational Research, Osaka University Graduate School of Medicine, Suita, Osaka565-0871, Japan
- Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka565-0871, Japan
| | - Daisuke Motooka
- Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka565-0871, Japan
| | - Shizuka Uchida
- Center for RNA Medicine, Department of Clinical Medicine, Aalborg University, Copenhagen SVDK-2450, Denmark
| | - Hideshi Ishii
- Department of Medical Data Science, Center of Medical Innovation and Translational Research, Osaka University Graduate School of Medicine, Suita, Osaka565-0871, Japan
| |
Collapse
|